Cenk GÜRBÜZ
(BEYKOZ ÜNİVERSİTESİ/MESLEK YÜKSEKOKULU/TIBBİ HİZMETLER VE TEKNİKLER BÖLÜMÜ/DİYALİZ)
Marcus J. DRAKE
(Bristol Urological Institute and Bristol Medical School, University of Bristol, Southmead Hospital, Bristol, UK)
Yıl: 2019Cilt: 45Sayı: 3ISSN: 2149-3235 / 2149-3057Sayfa Aralığı: 157 - 163İngilizce

76 0
Where can urodynamic testing help assess male lower urinary tract symptoms?
Urodynamic studies assess the function of the bladder and bladder outlet. They are often useful in the assessment and diagnosis of patients presenting with lower urinary tract symptoms (LUTS). The evidenceregarding the value and risks of invasive urodynamics remains insufficient. However, men with LUTS whoare assessed by invasive urodynamics are more likely to have their management changed and less likely toundergo surgery. This review discusses the role of urodynamic diagnosis and application in the diagnosisand treatment of male LUTS.
DergiDerlemeErişime Açık
  • 1. van Kerrebroeck P, Abrams P, Chaikin D, Donovan J, Fonda D, Jackson S, et al.. The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:179-83. [CrossRef]
  • 2. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006;50:1306-15. [CrossRef]
  • 3. Coyne KS, Sexton CC, Thompson CL, Milsom I, Irwin D, Kopp ZS, et al. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int 2009;104:352-60. [CrossRef]
  • 4. Radomski SB, Herschorn S, Naglie G. Acute urinary retention in men: a comparison of voiding and nonvoiding patients after prostatectomy. J Urol 1995;153:685-8. [CrossRef]
  • 5. Rosier PF, Szabó L, Capewell A, Gajewski JB, Sand PK, Hosker GL. Executive summary: The International Consultation on Incontinence 2008--Committee on: "Dynamic Testing"; for urinary or fecal incontinence. Part 2: Urodynamic testing in male patients with symptoms of urinary incontinence, in patients with relevant neurological abnormalities, and in children and in frail elderly with symptoms of urinary incontinence. Neurourol Urodyn 2010;29:146-52.
  • 6. Malde S, Nambiar AK, Umbach R, Lam TB, Bach T, Bachmann A, et al. Systematic review of the performance of noninvasive tests in diagnosing bladder outlet obstruction in men with lower urinary tract symptoms. Eur Urol 2017;71:391-402. [CrossRef]
  • 7. Abrams P, Blaivas JG, Stanton SL, Andersen JT. The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology. Scand J Urol Nephrol Suppl 1988;114:5-19.
  • 8. Schafer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, et al. Good urodynamic practices: Uroflowmetry filling cystometry, and pressure-flow studies. Neurourol Urodyn 2002;21:261-74. [CrossRef]
  • 9. Rosier PFWM, Schaefer W, Lose G, Goldman HB, Guralnick M, Eustice S, et al. International Continence Society Good Urodynamic Practices and Terms 2016: Urodynamics, uroflowmetry, cystometry, and pressure-flow study. Neurourol Urodyn 2017;36:1243-60. [CrossRef]
  • 10. Stohrer M, Goepel M, Kondo A, Kramer G, Madersbacher H, Millard R, et al. The standardization of terminology in neurogenic lower urinary tract dysfunction with suggestions for diagnostic procedures. Neurourol Urodyn 1999;18:139-58. [CrossRef]
  • 11. Abrams P, Buzelin JM, Griffiths D. The urodynamic assessment of lower urinary tract symptoms. In: Proceedings of the 4th International Consultation on BPH 1998;323-77.
  • 12. Schafer W. Analysis of bladder outlet function with the linearized passive urethral resistance relation, linPURR, and a disease-specific approach for grading obstruction: from complex to simple. World J Urol 1995;13:47-58. [CrossRef]
  • 13. Abrams P. Bladder outlet obstruction index, bladder contractility index, and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int 1999;84:14-5. [CrossRef]
  • 14. Gerstenberg TC, Andersen JT, Klarskov P, Ramirez D, Hald T. High flow infravesical obstruction in men: symptomatology, urodynamics and the results of surgery. J Urol 1982;127:943-5. [CrossRef]
  • 15. Osman NI, Chapple CR, Abrams P, Dmochowski R, Haab F, Nitti V, et al. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol 2014;65:389-98. [CrossRef]
  • 16. Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P. The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcome after transurethral resection of the prostate with a minimum 10-year urodynamic follow-up. BJU Int 2004;93:745-50. [CrossRef]
  • 17. Ghalayini IF, Al-Ghazo MA, Pickard RS. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention. BJU Int 2005;96:93-7. [CrossRef]
  • 18. Kuo HC. Videourodynamic analysis of pathophysiology of men with both storage and voiding lower urinary tract symptoms. Urology 2007;70:272-6. [CrossRef]
  • 19. Hashim H, Abrams P. Is the bladder a reliable witness for predicting detrusor overactivity? J Urol 2006;175:191-4.
  • 20. McVary K, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, et al. American urological association guideline: management of benign prostatic hyperplasia (BPH).Available at: https:// www.auanet.org/benign-prostatic-hyperplasia-(2010-reviewedand-validity-confrmed-2014). Accessed Dec 2017.
  • 21. Tanaka Y, Masumori N, Itoh N, Furuya S, Ogura H, Tsukamoto T. Is the short-term outcome of transurethral resection of the prostate afected by preoperative degree of bladder outletobstruction, status of detrusor contractility or detrusor overactivity? Int J Urol 2006;13:1398-404.
  • 22. Masumori N, Furuya R, Tanaka Y, Furuya S, Ogura H, Tsukamoto T. The 12-year symptomatic outcome of transurethral resection of the prostate for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction compared to the urodynamic fndings before surgery. BJU Int 2010;105:1429-33. [CrossRef]
  • 23. Kim M, Jeong CW, Oh SJ. Diagnostic value of urodynamic bladder outlet obstruction to select patients for transurethral surgery of the prostate: systematic review and meta-analysis. PLoS One 2017;27;12.
  • 24. Clement KD, Burden H, Warren K, Lapitan MC, Omar MI, Drake MJ. Invasive urodynamic studies for the management of lower urinary tract symptoms (LUTS) in men with voiding dysfunction. Cochrane Database Syst Rev 2015;28:CD011179.
  • 25. De Lima ML, Netto NR Jr. Urodynamic studies in the surgical treatment of benign prostatic hyperplasia. Int Braz J Urol 2003;29:418-22. [CrossRef]
  • 26. Kristjansson B. A randomised evaluation of routine urodynamics in patients with LUTS. Scand J Urol Nephrol Suppl 1999;33(Suppl 200):9.
  • 27. Bailey K, Abrams P, Blair PS, Chapple C, Glazener C, Horwood J, et al. Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM) for diagnosis and management of bladder outlet obstruction in men: study protocol for a randomised controlled trial. Trials 2015;16:567. [CrossRef]
  • 28. Selman LE, Ochieng CA, Lewis AL, Drake MJ, Horwood J. Recommendations for conducting invasive urodynamics for men with lower urinary tract symptoms: Qualitative interview findings from a large randomized controlled trial (UPSTREAM). Neurourol Urodyn 2019;38:320-9. [CrossRef]
  • 29. Kim M, Jeong CW, Oh SJ. Effect of Preoperative Urodynamic Detrusor Underactivity on Transurethral Surgery for Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis. J Urol 2018;199:237-44. [CrossRef]
  • 30. Seki N, Takei M, Yamaguchi A, Naito S. Analysis of Prognostic Factors Regarding the Outcome After a Transurethral Resection for Symptomatic Benign Prostatic Enlargement. Neurourol Urodyn 2006;25:428-32. [CrossRef]
  • 31. Van Venrooij GE, Van Melick HH, Eckhardt MD, Boon TA. Correlations of urodynamic changes with changes in symptoms and well-being after transurethral resection of the prostate. J Urol 2002;168:605-9. [CrossRef]
  • 32. DeNunzio C, Franco G, Rocchegiani A. The evolution of detrusoroveractivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction. J Urol 2003;169:535-9. [CrossRef]
  • 33. Fusco F, Palmieri A, Ficarra V, Giannarini G, Novara G, Longo N, et al. α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies. Eur Urol 2016;69:1091-101. [CrossRef]
  • 34. Reynard JM, Yang Q, Donovan JL, Peters TJ, Schafer W, de la Rosette JJ, et al. The ICS-BPH Study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction. Br J Urol 1998;82:619-23 [CrossRef].
  • 35. Barendrecht MM, Abrams P, Schumacher H, de la Rosette JJ, Michel MC. Do alpha1-adrenoceptor antagonists improve lower urinarytract symptoms by reducing bladder outlet resistance? Neurourol Urodyn 2008;27:226-30.
  • 36. Kaplan SA, McCammon K, Fincher R, Fakhoury A, He W. Safety and tolerability of solifenacin add-on therapy to alpha-blocker treated men with residual urgency and frequency. J Urol 2009;182:2825-30. [CrossRef]
  • 37. Kaplan SA, Roehrborn CG, Rovner ES, Carlsson M, Bavendam T, Guan Z. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA 2006;296:2319-28. [CrossRef]
  • 38. Drake MJ, Oelke M, Snijder R, Klaver M, Traudtner K, van Charldorp K, et al. Incidence of urinary retention during treatment with single tablet combinations of solifenacin+tamsulosin OCAS™ for up to 1 year in adult men with both storage and voiding LUTS: A subanalysis of the NEPTUNE/NEPTUNE II randomized controlled studies. PLoS One 2017;12:e0170726.
  • 39. Drake MJ, Sokol R, Coyne K, Hakimi Z, Nazir J, Dorey J, et al. Responder and health-related quality of life analyses in men with lower urinary tract symptoms treated with a fixed-dose combination of solifenacin and tamsulosin oral-controlled absorption system: results from the NEPTUNE study. BJU Int 2016;117:165-72. [CrossRef]
  • 40. Kaplan SA, He W, Koltun WD, Cummings J, Schneider T, Fakhoury A. Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized controlled trial. Eur Urol 2013;63:158-65. [CrossRef]
  • 41. Abrams P, Kaplan S, De Koning Gans HJ, Millard R. Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction. J Urol 2006;175:999-1004. [CrossRef]
  • 42. Selman LE, Ochieng CA, Lewis AL, Drake MJ, Horwood J. Recommendations for conducting invasive urodynamics for men with lower urinary tract symptoms: Qualitative interview findings from a large randomized controlled trial UPSTREAM. Neurourol Urodyn 2019;38:320-9. [CrossRef]
  • 43. Baker KR, Drutz HP, Barnes MD. Effectiveness of antibiotic prophylaxis in preventing bacteriuria after multichannel urodynamic investigations: a blind, randomized study in 124 female patients. Am J Obstet Gynecol 1991;165:679-81. [CrossRef]
  • 44. Gürbüz C, Güner B, Atış G, Canat L, Caşkurlu T. Are prophylactic antibiotics necessary for urodynamic study? Kaohsiung J Med Sci 2013;29:325-9.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.